CureMyWay is a science-based consultancy firm in the health and well being segment, strongly driving behavior change in patients, consumers, and caregivers. We work closely with a broad range of healthcare  corporate, start-ups companies, and providers from all over the world to bring decision science into the interactions with medical staff, consumers and patients.

Our highly experienced team combines industry  specialists from the US, Europe and Israel, as well as outstanding researchers from multiple scientific disciplines and digital-health professionals. CureMyWay’s projects tend to be straight-to-the-point, highly focused and critical for substantial ROI. We deal with topics such as low health literacy and patient comprehension, prescriber behavior, behavior change, chronic disease, and more.

Learn more about what CureMyWay can do for you

See our case studies

Who we are


Talya Miron Shatz

PhD, Co-founder, CEO & CSO

Prof. Talya Miron-Shatz is an accomplished scientist who over the past decade worked with Nobel Laureate Daniel Kahneman at Princeton University, taught consumer behavior at Wharton, and now heads the Center for Medical Decision Making. She consults pharma companies – Pfizer, Johnson&Johnson, BMS, Novartis, Abbvie, startups, media agencies – Edelman PR, FCB Health, PulseCX, and InTouch Solutions, and developers: Samsung, NantHealth. Leads advisory boards, and is an inspiring public speaker.


Ariel Shatz

Co-founder, VP of Products & Business Development

Ariel Shatz has nearly 30 years of experience in business development and marketing, mainly in the health-care service providers’ arena. Over the past decade, he was part of the group that led the growth of FreeMind, a nondilutive funding firm, into a worldwide leader in its field.